Brad Steenwyk, M.D. Print E-mail

Associate Professor

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

205-934-7424

Clinical Subspecialty and Area(s) of Interest

·         Cardiothoracic Anesthesia

Education and Degrees

·         University of Alabama at Birmingham School of Medicine, Medical Doctor, 1999

·         Baptist Health Systems, Internal Medicine Internship, 2000

·         University of Alabama at Birmingham School of  Medicine, Anesthesiology Residency, 2003      

Recent Publications (in last 5 years)

·         Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK.  Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. J Heart Lung Transplant. 2006 Jun;25(6):653-63

·          Nielsen VG, Steenwyk BL, Gurley WQ. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII. J Heart Lung Transplant. 2006 Oct;25(10):1247-52

·          Nielsen VG, Audu P, Cankovic L, Lyerly RT 3rd, Steenwyk BL, Armstead V, Powell G. Qualitative thrombelastographic detection of tissue factor in human plasma. Anesth Analg. 2007 Jan;104(1):59-64

·         Nielsen VG, Cankovic L, Steenwyk BL. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Blood Coagul Fibrinolysis. 2007 Jan;18(1):35-9

·         Steenwyk BL, Kirklin JK, Gurley WQ, Nielsen VG. The hemostatic history of a 15-month-old child implanted with a Berlin heart left ventricular assist device. Anesth Analg. 2007 Mar;104(3):538-40